- Home
- TTOO vs PRPO Comparison
TTOO vs PRPO Comparison
Compare TTOO & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- PRPO
- Stock Information
- Founded
- TTOO 2006
- PRPO N/A
- Country
- TTOO United States
- PRPO United States
- Employees
- TTOO N/A
- PRPO N/A
- Industry
- TTOO Medical/Dental Instruments
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- TTOO Health Care
- PRPO Industrials
- Exchange
- TTOO Nasdaq
- PRPO Nasdaq
- Market Cap
- TTOO 10.7M
- PRPO 8.8M
- IPO Year
- TTOO 2014
- PRPO N/A
- Fundamental
- Price
- TTOO $0.35
- PRPO $5.79
- Analyst Decision
- TTOO Hold
- PRPO
- Analyst Count
- TTOO 1
- PRPO 0
- Target Price
- TTOO $5.00
- PRPO N/A
- AVG Volume (30 Days)
- TTOO 1.0M
- PRPO 5.7K
- Earning Date
- TTOO 02-13-2025
- PRPO 11-06-2024
- Dividend Yield
- TTOO N/A
- PRPO N/A
- EPS Growth
- TTOO N/A
- PRPO N/A
- EPS
- TTOO N/A
- PRPO N/A
- Revenue
- TTOO $7,677,000.00
- PRPO $17,411,000.00
- Revenue This Year
- TTOO $50.31
- PRPO $75.18
- Revenue Next Year
- TTOO $117.92
- PRPO N/A
- P/E Ratio
- TTOO N/A
- PRPO N/A
- Revenue Growth
- TTOO N/A
- PRPO 31.31
- 52 Week Low
- TTOO $0.31
- PRPO $4.31
- 52 Week High
- TTOO $8.38
- PRPO $7.30
- Technical
- Relative Strength Index (RSI)
- TTOO 23.45
- PRPO 41.19
- Support Level
- TTOO $0.31
- PRPO $5.72
- Resistance Level
- TTOO $0.55
- PRPO $6.48
- Average True Range (ATR)
- TTOO 0.06
- PRPO 0.24
- MACD
- TTOO 0.01
- PRPO 0.01
- Stochastic Oscillator
- TTOO 8.97
- PRPO 0.00
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.